Literature DB >> 8149609

Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease.

L L Wu1, J Wu, S C Hunt, B C James, G M Vincent, R R Williams, P N Hopkins.   

Abstract

We measured plasma homocyst(e)ine [H(e)] and other coronary risk factors in 266 patients with early coronary artery disease from 170 families in which two or more siblings were affected and in 168 unmatched controls. The mean H(e) concentration adjusted for significant correlates (serum creatinine, uric acid, and low-density lipoprotein cholesterol) was 12.0 mumol/L in proband cases compared with 10.1 mumol/L in controls (P = 0.0001). Many (17.6%) of the proband cases had H(e) concentrations exceeding the 95th percentile for the controls (relative odds = 4.9, P < 0.001). H(e) among cases was bimodally distributed even after adjustment for concentrations of plasma vitamins. Concordant high H(e) was seen in at least 10 (12%) of 85 families with two or more affected siblings. We conclude that a substantial proportion of early familial coronary artery disease is probably related to production of high concentrations of H(e) by one or more major genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149609

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  17 in total

1.  Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc.

Authors:  Cuk-Seong Kim; Young-Rae Kim; Asma Naqvi; Santosh Kumar; Timothy A Hoffman; Saet-Byel Jung; Ajay Kumar; Byeong-Hwa Jeon; Dennis M McNamara; Kaikobad Irani
Journal:  Cardiovasc Res       Date:  2011-09-20       Impact factor: 10.787

2.  The effect of a subnormal vitamin B-6 status on homocysteine metabolism.

Authors:  J B Ubbink; A van der Merwe; R Delport; R H Allen; S P Stabler; R Riezler; W J Vermaak
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

4.  Association of blood lead and homocysteine levels among lead exposed subjects in Vietnam and Singapore.

Authors:  Sin Eng Chia; Safiyya Mohamed Ali; Bee Lan Lee; Gek Hsiang Lim; Su Jin; Nguyen-Viet Dong; Nguyen Thi Hong Tu; Choon Nam Ong; Kee Seng Chia
Journal:  Occup Environ Med       Date:  2007-04-20       Impact factor: 4.402

5.  Genes, greens, and homocysteine.

Authors:  R A Meleady; D A Mulcahy; I M Graham
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

Review 6.  Assessment of homocysteine status.

Authors:  H Refsum; T Fiskerstrand; A B Guttormsen; P M Ueland
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

7.  Heart attacks and homocysteine.

Authors:  I Graham; R Meleady
Journal:  BMJ       Date:  1996-12-07

Review 8.  Sex-related differences in oxidative stress and neurodegeneration.

Authors:  Mavis A Tenkorang; Brina Snyder; Rebecca L Cunningham
Journal:  Steroids       Date:  2017-12-20       Impact factor: 2.668

Review 9.  Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.

Authors:  Elisabetta Trabetti
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

10.  Plasma homocysteine in adolescents depends on the interaction between methylenetetrahydrofolate reductase genotype, lipids and folate: a seroepidemiological study.

Authors:  Ruth Gil-Prieto; Valentín Hernández; Beatriz Cano; Manuel Oya; Angel Gil
Journal:  Nutr Metab (Lond)       Date:  2009-10-05       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.